Research Article
Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients
Table 3
Multivariate Cox regression analysis including CEACAM1 protein expression.
| Overall survival | Variables in multivariate analysis | | | HR | 95% CI |
| CEACAM1 expression </> median | | 0.002 | 0.44 | 0.26–0.74 | FIGO stage | Ia–IIIb | 0.0001 | | | IIIc | 0.238 | 1.81 | 0.67–4.88 | IV | 0.002 | 5.15 | 1.87–14.21 | Residual tumor after surgery | No macroscopic tumor | 0.0004 | | | <1 cm | 0.002 | 2.33 | 1.37–3.97 | >1 cm | 0.002 | 2.90 | 1.47–5.71 |
| Recurrence-free survival | CEACAM1 expression </> median | | 0.291 | 0.80 | 0.53–1.21 | FIGO stage | Ia–IIIb | 0.001 | | | IIIc | 0.005 | 4.55 | 1.59–13.04 | IV | 0.0003 | 7.67 | 2.55–23.05 | Residual tumor after surgery | No macroscopic tumor | 0.0001 | | | <1 cm | 0.005 | 2.04 | 1.25–3.34 | >1 cm | 0.0001 | 3.60 | 1.89–6.88 |
|
|